Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Item No. 24553

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSObestatin is a 23-amino acid peptide hormone that is formed by cleavage of the ghrelin and obestatin prepropeptide.1 It is secreted by rat stomach, brain, perinatal pancreas, myenteric plexus, Leydig cells, and gastrointestinal mucosa and levels are decreased in rat plasma in response to fasting. Total obestatin levels are also reduced in rat fundus and intestine following treadmill exercise training.2 Obestatin inhibits release of insulin, somatostatin, and pancreatic polypeptide and stimulates glucagon release from mouse and rat pancreatic islets in vitro in a concentration-dependent manner.3 In vivo, obestatin (320 μg/kg) reduces food intake without affecting growth hormone or corticosterone release in mice.4 It also inhibits water intake and dehydration-induced vasopressin secretion in response to a hypovolemic challenge in rats.5
WARNING This product is not for human or veterinary use.
1. The effect of obestatin on porcine ovarian granulosa cells. Anim. Reprod. Sci. 108(1-2), 196-207 (2008).
2. Treadmill exercise reduces obestatin concentrations in rat fundus and small intestine. Biochem. Biophys. Res. Commun. 372(4), 741-745 (2008).
3. Proghrelin-
4. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J. Endocrinol. Invest. 29(8), RC16-RC18 (2006).
5. Obestatin inhibits vasopressin secretion: Evidence for a physiological action in the control of fluid homeostasis. J. Endocrinol. 196(3), 559-564 (2008).